Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Proinsulin

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 84206 refers to a laboratory test that measures the levels of proinsulin in the blood. Proinsulin is a precursor hormone to insulin, which is produced by the beta cells located in the pancreas, specifically within the islets of Langerhans. This test is significant as it provides insights into the body's insulin production and can help in assessing various metabolic conditions. To perform this test, a blood sample is collected through a procedure known as venipuncture, which is a separate reportable service. The serum obtained from the blood sample is then analyzed using a qualitative enzyme-linked immunosorbent assay (ELISA), a common laboratory technique used to detect and quantify proteins, hormones, and other substances in biological samples. The measurement of proinsulin levels is particularly relevant in the context of pre-diabetes and the progression toward type 2 diabetes mellitus, as elevated levels may indicate an impaired insulin response. Additionally, high proinsulin levels can be associated with several medical conditions, including benign or malignant B-cell tumors of the pancreas, renal failure, cirrhosis, and hyperthyroidism, making this test a valuable tool in the diagnostic process for various endocrine and metabolic disorders.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The proinsulin test (CPT® Code 84206) is indicated for several clinical scenarios, particularly in the assessment of metabolic and endocrine disorders. The following conditions may warrant the performance of this test:

  • Pre-diabetes This test is often utilized to evaluate individuals who are at risk of developing type 2 diabetes mellitus, helping to identify early metabolic changes.
  • Type 2 Diabetes Mellitus It is used to monitor the progression of diabetes and the body's insulin production capabilities.
  • B-cell Tumors Elevated proinsulin levels may indicate the presence of benign or malignant tumors originating from B-cells in the pancreas.
  • Renal Failure The test can assist in understanding insulin dynamics in patients with compromised kidney function.
  • Cirrhosis Proinsulin levels may be affected in patients with liver disease, making this test relevant for assessing liver function.
  • Hyperthyroidism The test may also be indicated in patients with hyperthyroid conditions, as hormonal imbalances can influence insulin production.

2. Procedure

The procedure for obtaining a proinsulin test involves several key steps that ensure accurate measurement of proinsulin levels in the blood. The following outlines the procedural steps:

  • Step 1: Patient Preparation Prior to the blood draw, the patient may be instructed to fast for a specific period, although this may vary based on the physician's orders. Proper preparation is essential to obtain reliable test results.
  • Step 2: Venipuncture A qualified healthcare professional performs venipuncture to collect a blood sample. This involves the insertion of a needle into a vein, typically in the arm, to draw blood into a collection tube. The procedure is performed using sterile techniques to minimize the risk of infection.
  • Step 3: Serum Separation After collection, the blood sample is processed to separate the serum from the cellular components. This is typically done by centrifugation, which spins the sample at high speeds to separate the liquid serum from the blood cells.
  • Step 4: Testing The serum is then subjected to a qualitative enzyme-linked immunosorbent assay (ELISA). This laboratory technique involves adding specific antibodies that bind to proinsulin, allowing for the quantification of proinsulin levels in the sample.
  • Step 5: Result Interpretation Once the assay is complete, the results are analyzed and interpreted by a qualified laboratory professional. The findings are then reported to the ordering physician for further evaluation and management of the patient's condition.

3. Post-Procedure

After the proinsulin test is performed, there are generally no specific post-procedure care requirements for the patient. However, it is common for patients to be advised to maintain hydration and to monitor the venipuncture site for any signs of bruising or discomfort. The results of the test will be reviewed by the physician, who will discuss the implications of the findings with the patient and determine any necessary follow-up actions or additional testing based on the results. It is important for patients to understand that elevated proinsulin levels may require further investigation to identify underlying conditions or to adjust treatment plans accordingly.

Short Descr ASSAY OF PROINSULIN
Medium Descr ASSAY OF PROINSULIN
Long Descr Proinsulin
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GZ Item or service expected to be denied as not reasonable and necessary
Date
Action
Notes
2013-01-01 Changed Medium Descriptor changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"